Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important?

The aim of this study was to examine the impact of Friedreich ataxia (FRDA) on quality of life (QOL) using a generic tool to explore factors potentially associated with health status. Sixty‐three individuals with genetically confirmed FRDA, self completed the Medical Outcomes Study 36 item Short Form Health Survey Version 2 (SF‐36V2) and were assessed using the FRDA Rating Scale. Disease‐specific, demographic, and social characteristics were also recorded. SF‐36V2 results were compared with Australian population norms. Sample subgroups of disease severity and age at disease onset were reviewed. Physical and mental component summaries were examined in relation to clinical and social characteristics using multiple linear regression. QOL is significantly worse in individuals with FRDA compared with population norms. Those with severe disease did not perceive a lower QOL than those with mild or moderate disease except in their physical functioning. A later age of onset and increased disease severity were negatively associated with physical QOL, whilst, increased disease duration was positively associated with mental QOL. There were limitations associated with the use of SF‐36V2 in the FRDA population. Further exploration of health‐related QOL and FRDA may benefit from the use of a more appropriate generic tool.

[1]  R. Osborne,et al.  The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms , 2007, Quality of Life Research.

[2]  J. Hobart,et al.  Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[3]  C. Angelini,et al.  Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study , 2006, European journal of neurology.

[4]  K. Pfeiffer,et al.  Association of factors influencing health‐related quality of life in MS , 2006, Acta neurologica Scandinavica.

[5]  M. T. Pellecchia,et al.  Health‐related quality of life in multiple system atrophy , 2006, Movement disorders : official journal of the Movement Disorder Society.

[6]  M. Hallett,et al.  Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale , 2005, Neurology.

[7]  A. Thompson,et al.  Socio-demographic variables are limited predictors of health status in multiple sclerosis , 2003, Journal of Neurology.

[8]  A J Thompson,et al.  Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles , 2003, Journal of neurology, neurosurgery, and psychiatry.

[9]  A Schrag,et al.  How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population , 2000, Movement disorders : official journal of the Movement Disorder Society.

[10]  A. Thompson,et al.  Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[11]  R Williamson,et al.  Review articles Friedreich ataxia: an overview , 1999 .

[12]  A. Lloyd Assessment of the SF-36 version 2 in the United Kingdom. , 1999, Journal of epidemiology and community health.

[13]  T. Riise,et al.  Quality of life in multiple sclerosis , 1999, Neurology.

[14]  M. Koenig,et al.  Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Harding Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. , 1981, Brain : a journal of neurology.

[16]  H. Karpatkin Quality of Life in Multiple Sclerosis: Measuring the Disease Effects More Broadly. , 2000 .